Literature DB >> 23810727

Online in vivo dosimetry in high dose rate prostate brchytherapy with MOSkin detectors: in phantom feasibility study.

G Gambarini1, M Carrara, C Tenconi, N Mantaut, M Borroni, D Cutajar, M Petasecca, I Fuduli, M Lerch, E Pignoli, A Rosenfeld.   

Abstract

MOSkin detectors were studied to perform real-time in vivo dose measurements in high dose rate prostate brachytherapy. Measurements were performed inside an urethral catheter in a gel phantom simulating a real prostate implant. Measured and expected doses were compared and the discrepancy was found to be within 8.9% and 3.8% for single MOSkin and dual-MOSkin configurations, respectively. Results show that dual-MOSkin detectors can be profitably adopted in prostate brachytherapy treatments to perform real-time in vivo dosimetry inside the urethra.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Keywords:  High dose rate; In vivo dosimetry; MOSFET; Prostate brachytherapy

Mesh:

Year:  2013        PMID: 23810727     DOI: 10.1016/j.apradiso.2013.06.001

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

Review 1.  In vivo dosimetry: trends and prospects for brachytherapy.

Authors:  G Kertzscher; A Rosenfeld; S Beddar; K Tanderup; J E Cygler
Journal:  Br J Radiol       Date:  2014-07-08       Impact factor: 3.039

Review 2.  Glucose signaling, AtRGS1 and plant autophagy.

Authors:  Yue Jiao; Wenxue Lei; Wan Xu; Wen-Li Chen
Journal:  Plant Signal Behav       Date:  2019-05-06

3.  Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement.

Authors:  Kimberley Legge; Peter B Greer; Daryl J O'Connor; Lee Wilton; Matthew Richardson; Perry Hunter; Alex Wilfert; Jarad Martin; Anatoly Rosenfeld; Dean Cutajar
Journal:  Radiat Oncol       Date:  2017-02-27       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.